Kynurenines and PACAP in Migraine: Medicinal Chemistry and Pathogenetic Aspects
Open Access
- 22 June 2017
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 24 (13) , 1332-1349
Abstract
Background: Migraine is a highly disabling neurovascular primary headache disorder, with its exact pathomechanism being still unrevealed. The current leading hypotheses are based on the sensitization and activation of the trigeminovascular system. Objective: To review the literature with focus on the effects of kynurenines (L-kynurenine and kynurenic acid) and pituitary adenylate cyclase-activating polypeptide on the regulation of the trigeminovascular system. Method: A literature search was conducted to identify preclinical and clinical publications (198 references) by using the keywords ‘kynurenines’, ‘pituitary adenylate cyclase-activating polypeptide’, and ‘migraine’ in the database of MEDLINE/PubMed up to 10 September 2016 for topical review. Additional filters used included ‘review’, ‘systematic review’, ‘original article’, and ‘English language’. Results: L-kynurenine and kynurenic acid act on the glutamatergic system at the level of the second-order nociceptive neurons in the trigeminal nucleus caudalis. Pituitary adenylate cyclase- activating polypeptide is released from the peripheral nerve endings of the trigeminal pseudounipolar neurons and causes vasodilation and mast cell degranulation, leading to consequent peripheral sensitization of the dural nociceptors. Centrally released pituitary adenylate cyclase-activating polypeptide in the trigeminal nucleus caudalis results in the central sensitization of the second-order neurons. The sensitization process leads to the characteristic features of migraine. Conclusion: L-kynurenine, kynurenic acid, and pituitary adenylate cyclase-activating polypeptide may have fundamental roles in the initiation of migraine headache attacks.Keywords
This publication has 136 references indexed in Scilit:
- Metabotropic glutamate receptor 5: a target for migraine therapyAnnals of Clinical and Translational Neurology, 2016
- Pituitary adenylate cyclase activating polypeptide and migraineAnnals of Clinical and Translational Neurology, 2014
- Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complexJournal of Neural Transmission, 2014
- Where does a migraine attack originate? In the brainstemJournal of Neural Transmission, 2012
- The kynurenine system and immunoregulationJournal of Neural Transmission, 2011
- Kynurenines and headacheJournal of Neural Transmission, 2011
- Migraine is a neuronal diseaseJournal of Neural Transmission, 2010
- Structure, expression, and function of kynurenine aminotransferases in human and rodent brainsCellular and Molecular Life Sciences, 2009
- The Janus-face kynurenic acidJournal of Neural Transmission, 2008
- Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine modelJournal of Neural Transmission, 2006